{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=AVM&page=5", "query": { "condition": "AVM", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 103, "total_pages": 11, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=AVM&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=AVM&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T16:48:33.694Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06807099", "title": "WRAP North America", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Venous Stenosis", "Venous Occlusion" ], "interventions": [ { "name": "Merit WRAPSODY® Cell Impermeable Endoprosthesis (WRAPSODY CIE)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Merit Medical Systems, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2025-07-31", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 14, "location_summary": "Dothan, Alabama • Phoenix, Arizona • Riverside, California + 11 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Riverside", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06807099" }, { "nct_id": "NCT04874558", "title": "Ultra-low-dose Chest CT for HHT", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hereditary Hemorrhagic Telangiectasia" ], "interventions": [ { "name": "Ultra-low dose chest CT", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "17 Years", "sex": "ALL", "summary": "1 Year to 17 Years" }, "enrollment_count": 3, "start_date": "2021-04-21", "completion_date": "2026-03-07", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04874558" }, { "nct_id": "NCT02106962", "title": "Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Arteriovenous Fistula" ], "interventions": [ { "name": "Topical Tranexamic Acid 5% with bacitracin", "type": "DRUG" }, { "name": "Topical Tranexamic Acid 25% with bacitracin", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "California Institute of Renal Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2014-04", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2017-09-25", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 3, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02106962" }, { "nct_id": "NCT05491980", "title": "Florida Cerebrovascular Disease Biorepository and Genomics Center", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cerebrovascular Disease", "Ischemic Stroke", "Transient Ischemic Attack", "Intracerebral Hemorrhage", "Aneurysmal Subarachnoid Hemorrhage", "Vascular Dementia", "Anoxic Brain Injury", "Unruptured Intracranial Aneurysm", "Carotid Artery Stenosis Symptomatic", "Asymptomatic Carotid Artery Stenosis", "Non-Aneurysmal Perimesencephalic Subarachnoid Haemorrhage", "Cerebral Venous Thrombosis", "Moyamoya Disease", "Fibromuscular Dysplasia", "Subarachnoid Hemorrhage", "Leukoaraiosis", "Arteriovenous Fistula", "Reversible Cerebral Vasoconstriction Syndrome", "CADASIL" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2022-08-02", "completion_date": "2030-06", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05491980" }, { "nct_id": "NCT00389935", "title": "Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arteriovenous Malformation", "Hereditary Hemorrhagic Telangiectasia", "Hematochezia", "Melena" ], "interventions": [ { "name": "Thalidomide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northport Veterans Affairs Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2006-10", "completion_date": "2011-07", "has_results": false, "last_update_posted_date": "2011-08-02", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 3, "location_summary": "Augusta, Georgia • Worcester, Massachusetts • Northport, New York", "locations": [ { "city": "Augusta", "state": "Georgia" }, { "city": "Worcester", "state": "Massachusetts" }, { "city": "Northport", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00389935" }, { "nct_id": "NCT01806545", "title": "An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arteriovenous Fistula" ], "interventions": [ { "name": "SRM003", "type": "BIOLOGICAL" }, { "name": "Participating Site's standard practice", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2013-03-26", "completion_date": "2014-10-27", "has_results": true, "last_update_posted_date": "2021-06-08", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 47, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Fresno, California + 41 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01806545" }, { "nct_id": "NCT01468506", "title": "Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Kidney Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Baptist Health South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2011-09", "completion_date": "2014-09", "has_results": false, "last_update_posted_date": "2014-09-25", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01468506" }, { "nct_id": "NCT07483255", "title": "A Phase II Trial of Fetal Embolization for Vein of Galen Malformation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vein of Galen Malformations" ], "interventions": [ { "name": "Fetal embolization of vein of Galen malformation using Target XL and XXL Detachable Coils", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Darren Orbach", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 20, "start_date": "2026-07-20", "completion_date": "2032-12", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07483255" }, { "nct_id": "NCT05425056", "title": "A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complication of Renal Dialysis", "End Stage Renal Disease", "End Stage Kidney Disease", "ESRD", "Chronic Kidney Failure", "Complication of Hemodialysis", "Vascular Access Complication", "Arteriovenous Fistula" ], "interventions": [ { "name": "Sirolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vascular Therapies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 136, "start_date": "2022-08-26", "completion_date": "2025-08-29", "has_results": true, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 17, "location_summary": "San Diego, California • Torrance, California • Washington D.C., District of Columbia + 13 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05425056" }, { "nct_id": "NCT04054440", "title": "Outpatient Office Based Endovascular Procedures", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Venous Insufficiency", "Peripheral Arterial Disease", "Dialysis Access Malfunction", "Arterio-venous Fistula", "Thoracic Outlet Syndrome", "Vertebral Artery Insufficiency", "Varicose Veins" ], "interventions": [], "intervention_types": [], "sponsor": "Methodist Health System", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26000, "start_date": "2014-06-20", "completion_date": "2024-05-17", "has_results": false, "last_update_posted_date": "2026-03-24", "last_synced_at": "2026-10-28T16:48:33.694Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04054440" } ] }